ASCO Action Center
Immerse yourself in the latest oncological breakthroughs with the ASCO Action Center, which offers an in-depth look at the research and clinical advancements unveiled at the American Society of Clinical Oncology (ASCO) Annual Meeting and even its affiliated conferences like the Genitourinary Cancers (ASCO-GU) Symposium. Gain exclusive access to the expert analyses, dynamic discussions, and cutting-edge treatment strategies presented at the conference that are redefining cancer care.
Episodes 1-15 of 17
Optimizing Nivolumab in NSCLC: Implications for Cost, Access, and Outcomes
Project Oncology®Optimizing Nivolumab in NSCLC: Implications for Cost, Access, and Outcomes
Biomarker Breakthroughs: A Look at What’s Next for Kidney Cancer Care
Project Oncology®Biomarker Breakthroughs: A Look at What’s Next for Kidney Cancer Care
One Year or Two? DANTE Trial Explores Immunotherapy Duration in Metastatic Melanoma
Project Oncology®One Year or Two? DANTE Trial Explores Immunotherapy Duration in Metastatic Melanoma
Predicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures
Project Oncology®Predicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures
Overall Survival with Neoadjuvant Therapy in HNSCC: Examining Real-World Data
Project Oncology®Overall Survival with Neoadjuvant Therapy in HNSCC: Examining Real-World Data
Immune Checkpoint Inhibitors Show Promise in Patients with Oncogene Driver-Negative NSCLC Who Have Never Smoked
Project Oncology®Immune Checkpoint Inhibitors Show Promise in Patients with Oncogene Driver-Negative NSCLC Who Have Never Smoked
- advertisement
TILplus Score as a Potential Predictive Biomarker in First-Line ICI Therapy for mccRCC
Project Oncology®TILplus Score as a Potential Predictive Biomarker in First-Line ICI Therapy for mccRCC
A Unique Look at the Current and Future Directions of Cancer Vaccines
Project Oncology®A Unique Look at the Current and Future Directions of Cancer Vaccines
The Power of Patient Advocacy in Daily Clinical Practice
Project Oncology®The Power of Patient Advocacy in Daily Clinical Practice
Treating High-Risk Biochemically Recurrent Prostate Cancer: An Update from ASCO-GU
Project Oncology®Treating High-Risk Biochemically Recurrent Prostate Cancer: An Update from ASCO-GU
- advertisement
Are Practicing Ob-Gyn Oncologists on Your Speed Dial?
Clinician's RoundtableAre Practicing Ob-Gyn Oncologists on Your Speed Dial?
Bladder Cancer Treatment and Preserving Quality of Life
Medical Breakthroughs from Penn MedicineBladder Cancer Treatment and Preserving Quality of Life
Weighing Testosterone Therapy in Patients With Prostate Cancer
Focus on Women's and Men’s HealthWeighing Testosterone Therapy in Patients With Prostate Cancer
